Aurobindo Pharma, KEC International, Blue Dart Express Q4 Results Today — Earnings Estimates

Aurobindo Pharma Ltd., KEC International Ltd., Blue Dart Express Ltd. are among the companies that are set to announce their fourth-quarter results on Monday.

Here's a look at the consensus analysts' estimates that are compiled by Bloomberg.

Aurobindo Pharma is estimated to report a 9.4% jump in consolidated revenue at Rs 8,197 crore. Its Ebitda is projected at Rs 1,826.5 crore, with a margin of 12.3%. The estimated net profit stands at Rs 1,013 crore.

KEC International is estimated to have a revenue of Rs 7,078 crore. The Ebitda is projected at Rs 554.5 crore, with a margin of 7.8%. The estimated net profit stands at Rs 261 crore.

Bayer CropScience is expected to show a revenue of Rs 913 crore. The company's Ebitda is estimated at Rs 130 crore, with a margin of 14.2%. The projected net profit is Rs 99.4 crore.

Blue Dart Express is estimated to report a revenue of Rs 1,450 crore. Its Ebitda is projected at Rs 234 crore, with a margin of 16.1%. The estimated net profit stands at Rs 76 crore.

RateGain Travel Tech is estimated to have a revenue of Rs 266 crore. The Ebitda is projected at Rs 58 crore, with a margin of 21.8%. The estimated net profit stands at Rs 53 crore.

Action Construction Equipment, Akums Drugs and Pharmaceuticals, Aurobindo Pharma, Awfis Space Solutions, Balaji Amines, Bayer CropScience, Blue Dart Express, Capacite Infraprojects, Brainbees Solutions, General Insurance Corporation of India, Gillette India, Goldiam International, Hi-Tech Pipes, Infibeam Avenues, KEC International, Lumax Industries, Maharashtra Seamless, Nazara Technologies, Olectra Greentech, Orchid Pharma, Apeejay Surrendra Park Hotels, PTC India, RateGain Travel Technologies, Schneider Electric Infrastructure, Shilpa Medicare, Stylam Industries, Sumitomo Chemical India, Vadilal Industries, Venus Pipes & Tubes and Yatharth Hospital & Trauma Care Services.